Johnson & Johnson (JNJ): Are Its Medical Device Deals Paying Off?

Johnson & Johnson guides to 8.2% adjusted EPS growth at its 2026 midpoint, compared with approximately 7% implied by 2026 ...
BioSpace

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

The Company remains on track to complete 12-month visits by early Q2 2027. Envoy Medical has submitted two of the four ...
BioSpace

Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)

Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...

Billionaires and Trump Were Buying This Healthcare Stock

Abbott Laboratories (NYSE:ABT) is one of the top 10 picks in President Trump’s latest stock portfolio. Trump bought $1 ...
Sideprojects on MSN

9 medical breakthroughs of 2026 that could change the future of healthcare

Medical researchers reported remarkable progress in 2026, introducing new treatments and technologies that could transform ...

Specialist fees regulation is a quagmire as doctors take lead

Soon if you visit a medical specialist, you may notice a fact sheet plastered on the wall. It will encourage you to ask questions, and outline five simple things to consider when speaking to your ...
ABC7 New York

Second 9/11 victim identified with breakthrough genetic genealogy, NYC officials say

A second victim of the September 11 attacks has been identified with breakthrough genetic genealogy, which combines DNA ...